Noven Pharmaceuticals Inc. Receives FDA Warning Letter Related to Mid-2007 Facility Inspection

January 10, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MIAMI--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) announced that yesterday it received a warning letter from the U.S. Food and Drug Administration (FDA) related to a prior on-site inspection of Noven’s Miami manufacturing facility.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory